The Law and Ethics of the Pharmaceutical Industry

Elsevier (2005)
Abstract
As one of the most massive and successful business sectors, the pharmaceutical industry is a potent force for good in the community, yet its behaviour is frequently questioned: could it serve society at large better than it has done in the recent past? Its own internal ethics, both in business and science, may need a careful reappraisal, as may the extent to which the law - administrative, civil and criminal - succeeds in guiding (and where neccessary contraining) it. The rules of behavior that may be considered to apply to today's pharmaceutical industry have emerged over a very long period and the process goes on. Even the immensely detailed standards for quality, safety and efficacy laid down in drug law and regulation during the second half of the twentieth century have their limitations as tools for ensuring that the public interest is well served. In particular, national and regional regulatory agencies are heavily dependent on industrial data for their decision-making, their standards and competence vary, and even the existing network of agencies does not cover the entire world. What is more there are many areas of law and regulation affecting the industry, concerning for example the pricing of medicines, the conduct of clinical studies, the health protection of workers and concern for the environment. In some fields it is indeed hardly possible to maintain standards through regulation. Professor N.M. Graham Dukes, a physician and lawyer with long term experience in industrial research management, academic study and international drug policy, provides here a powerfully documented analysis into the way this industry thinks, acts, and is viewed, and examines the current trends pointing to change. *Provides a balanced picture of the current role of the pharmaceutical industry in society *Includes indices of conventions, laws, and regulations; as well as judicial and disciplinary cases *This is the only book addressing the legal implications of big pharma activities and ethical standards
Keywords Drugs Law and legislation  Pharmaceutical industry Moral and ethical aspects  Pharmaceutical industry Standards
Categories (categorize this paper)
Buy the book $115.96 used (39% off)   $170.00 new   $190.00 direct from Amazon    Amazon page
Call number K3636.D853 2005
ISBN(s) 0444518681   9780444518682
Options
 Save to my reading list
Follow the author(s)
Edit this record
My bibliography
Export citation
Find it on Scholar
Mark as duplicate
Request removal from index
Revision history
Download options
Our Archive


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 29,530
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library
References found in this work BETA

No references found.

Add more references

Citations of this work BETA

Add more citations

Similar books and articles
Intellectual Property and Pharmaceutical Drugs.Richard T. de George - 2005 - Business Ethics Quarterly 15 (4):549-575.
Big Pharma: A Story of Success in a Market Economy. [REVIEW]Joao Calinas-Correia - 2013 - Medicine, Health Care and Philosophy 16 (2):305-309.
Bioindustry Ethics.David Finegold (ed.) - 2005 - Elsevier Academic Press.
Big Pharma: A Former Insider's View. [REVIEW]David Badcott - 2013 - Medicine, Health Care and Philosophy 16 (2):249-264.
Manual for Research Ethics Committees.Sue Eckstein (ed.) - 2003 - Cambridge University Press.
Ethics and the Pharmaceutical Industry. [REVIEW]Joakim Sandberg - 2010 - European Journal of Health Law 17:211-214.
Added to PP index
2011-06-02

Total downloads
26 ( #209,810 of 2,210,802 )

Recent downloads (6 months)
1 ( #357,944 of 2,210,802 )

How can I increase my downloads?

Monthly downloads
My notes
Sign in to use this feature